The role of board-level clinical leaders in QI
|Starts:||12:00 13 Nov 2017|
|Ends:||13:30 13 Nov 2017|
|What is it:||Seminar|
|Organiser:||Manchester Business School|
|Who is it for:||University staff, Adults, Alumni, Current University students|
Alliance Manchester Business School's Health Services Research Centre present a research seminar:
Dr Lorelei Jones: "Health systems world-wide are increasingly holding boards of health care organisations accountable for the quality of care that they provide. Previous empirical research has found associations between certain board practices and higher quality patient care; however little is known about how boards govern for quality improvement (QI).
In this seminar I will be discussing findings from fieldwork conducted over 30 months in 15 healthcare provider organisations in England. Our analysis explored variation in how boards enacted governance of quality improvement. From our analysis, and using existing evidence of the links between board practices and quality of care, we constructed a measure of QI governance maturity. We then compared organisations to identify the characteristics of those with mature QI governance.
We found that boards with higher levels of maturity in relation to governing for QI had the following characteristics: explicitly prioritizing QI; balancing short term (external) priorities with long term (internal) investment in QI; using data for QI, not just quality assurance; engaging staff and patients in QI; and encouraging a culture of continuous improvement. These characteristics appeared to be particularly enabled and facilitated by board-level clinical leaders."
Light luncheon refreshment will be provided at the beginning of this seminar.
Travel and Contact Information
Dover Street Building